Mosaic HIV-1 Gag antigens can be processed and presented to human HIV-specific CD8+ T cells.
Polyvalent mosaic HIV immunogens offer a potential solution for generating vaccines that can elicit immune responses against genetically diverse viruses. However, it is unclear whether key T cell epitopes can be processed and presented from these synthetic Ags and recognized by epitope-specific huma...
Main Authors: | Ndhlovu, Z, Piechocka-Trocha, A, Vine, S, McMullen, A, Koofhethile, K, Goulder, P, Ndung'u, T, Barouch, D, Walker, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.
by: Julg, B, et al.
Published: (2010) -
HLA-B*4201-restricted inter- and intra-protein-specific differences in anti-HIV CD8(+) T-cell epitope efficacy
by: Kloverpris, H, et al.
Published: (2010) -
Polyvalent Gag-specific CD8 T-cells with enhanced functional properties are enriched in HIV-1 clade C infected individuals with lower viral loads
by: Julg, B, et al.
Published: (2009) -
Impact of immune-driven sequence variation in HIV-1 subtype C Gag-Protease on viral fitness and disease progression
by: Wright, J, et al.
Published: (2009) -
Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
by: Wright, J, et al.
Published: (2012)